Analysis and Commentary 1/5/18 Analysis and Commentary 1/5/18 Ensuring an Effective and Motivated Workforce Read More Analysis and Commentary 12/22/17 Analysis and Commentary 12/22/17 From This Week's CR into FY 19: More Alliance Priorities Read More Analysis and Commentary 12/15/17 Analysis and Commentary 12/15/17 Right Down to the Wire: Beware and Be Warned! Read More Analysis and Commentary 12/7/17 Analysis and Commentary 12/7/17 "All of Our Voices" Are Going to Be Essential Read More Analysis and Commentary 12/1/17 Analysis and Commentary 12/1/17 No One’s Interests Would Be Served by a Shutdown Read More Analysis and Commentary 11/17/17 Analysis and Commentary 11/17/17 Much to Be Thankful For Read More Analysis and Commentary 11/10/17 Analysis and Commentary 11/10/17 Whatever Makes FDA Stronger (in Resources) ... Read More Analysis and Commentary 11/4/17 Analysis and Commentary 11/4/17 FDA Is Its People ... and They Need Our Support Read More Analysis and Commentary 10/27/17 Analysis and Commentary 10/27/17 Building a Truely 21st Century Regulatory Agency Read More Analysis and Commentary 10/20/17 Analysis and Commentary 10/20/17 Not Your Father's FDA Read More Analysis and Commentary 10/12/17 Analysis and Commentary 10/12/17 The FDA Deserves Special Consideration at Budget-Time Read More Analysis and Commentary 10/5/17 Analysis and Commentary 10/5/17 FDA Stakeholders Need to Start to "Up Our Game" Read More Analysis and Commentary 9/29/17 Analysis and Commentary 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More Analysis and Commentary 9/8/17 Analysis and Commentary 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More Analysis and Commentary 8/11/17 Analysis and Commentary 8/11/17 It's Going to Get Tougher From Here Read More Analysis and Commentary 8/4/17 Analysis and Commentary 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More Analysis and Commentary 7/27/17 Analysis and Commentary 7/27/17 Challenges and Threats to FDA Resources: An Update Read More Analysis and Commentary 7/21/17 Analysis and Commentary 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More Analysis and Commentary 6/29/17 Analysis and Commentary 6/29/17 Happier ... But Not Out of the Woods by Any Means Read More Analysis and Commentary 6/23/17 Analysis and Commentary 6/23/17 Fuzzy Math and New Score (but Not on Goal) Read More Newer Posts Older Posts
Analysis and Commentary 1/5/18 Analysis and Commentary 1/5/18 Ensuring an Effective and Motivated Workforce Read More
Analysis and Commentary 12/22/17 Analysis and Commentary 12/22/17 From This Week's CR into FY 19: More Alliance Priorities Read More
Analysis and Commentary 12/15/17 Analysis and Commentary 12/15/17 Right Down to the Wire: Beware and Be Warned! Read More
Analysis and Commentary 12/7/17 Analysis and Commentary 12/7/17 "All of Our Voices" Are Going to Be Essential Read More
Analysis and Commentary 12/1/17 Analysis and Commentary 12/1/17 No One’s Interests Would Be Served by a Shutdown Read More
Analysis and Commentary 11/10/17 Analysis and Commentary 11/10/17 Whatever Makes FDA Stronger (in Resources) ... Read More
Analysis and Commentary 11/4/17 Analysis and Commentary 11/4/17 FDA Is Its People ... and They Need Our Support Read More
Analysis and Commentary 10/27/17 Analysis and Commentary 10/27/17 Building a Truely 21st Century Regulatory Agency Read More
Analysis and Commentary 10/12/17 Analysis and Commentary 10/12/17 The FDA Deserves Special Consideration at Budget-Time Read More
Analysis and Commentary 10/5/17 Analysis and Commentary 10/5/17 FDA Stakeholders Need to Start to "Up Our Game" Read More
Analysis and Commentary 9/29/17 Analysis and Commentary 9/29/17 Plus ça Change, Plus c'est la Même Chose Read More
Analysis and Commentary 9/8/17 Analysis and Commentary 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More
Analysis and Commentary 8/11/17 Analysis and Commentary 8/11/17 It's Going to Get Tougher From Here Read More
Analysis and Commentary 8/4/17 Analysis and Commentary 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More
Analysis and Commentary 7/27/17 Analysis and Commentary 7/27/17 Challenges and Threats to FDA Resources: An Update Read More
Analysis and Commentary 7/21/17 Analysis and Commentary 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More
Analysis and Commentary 6/29/17 Analysis and Commentary 6/29/17 Happier ... But Not Out of the Woods by Any Means Read More
Analysis and Commentary 6/23/17 Analysis and Commentary 6/23/17 Fuzzy Math and New Score (but Not on Goal) Read More
